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INTRODUCTION
The human gastrointestinal (GI) tract har-
bors the largest number and concentra-
tion of microbes found in the human
body. Perturbations in the gut microbial
ecosystem have also been associated with
conditions as diverse as chronic GI dis-
eases (e.g., Crohn’s disease, ulcerative col-
itis), metabolic disorders (e.g., diabetes
types 1 and 2, obesity) and antibiotic use
(for a review see Sekirov et al., 2010).
Metagenomic culture-independent meth-
ods have enabled the unraveling of the
complexity of the gut microbiota (Rajilic´-
Stojanovic´ et al., 2009). Given the con-
siderable inter-individual diversity in the
actual composition of the microbiota, sig-
nificant collaborative attempts have been
made to systematize the available knowl-
edge (Arumugam et al., 2011; Human
Microbiome Project Consortium, 2012)
and identify “core” microbiota that are
conserved among humans to facilitate
meaningful comparisons (Huse et al.,
2012). Changes in the microbial com-
position also take place with age, with
a high degree of variability at the two
extremes of infancy and old age, punctu-
ated by comparative stability during adult-
hood (for reviews, see Woodmansey, 2007;
O’Toole and Claesson, 2010). Given that
increases in life expectancy will likely result
in an increase in the elderly population
worldwide, analysis of the contribution of
the microbiota to healthy aging assumes
greater significance (for a recent review,
see Tiihonen et al., 2010).
Age-related spatio-temporal variations
in themicrobiota are best viewedwithin an
ecological- evolutionary framework (see
review by Costello et al., 2012). Diet is a
major, controllable environmental factor
influencing the composition of the host
microbiome, with the high-fat, sugar-rich
Western diet contributing to a Bacteroides-
dominant microbiome and high-fiber diet
to one dominated by Firmicutes with
a strong correlation between long-term
diet and enterotypes (Wu et al., 2011).
In terms of ecological succession, the
Bifidobacterium-dominated microbiota of
the infant changes over time into the
Bacteroidetes- and Firmicutes-dominated
microbiota of the adult (Ottman et al.,
2012), remaining fairly stable through
adulthood in the absence of perturbations
like long-term dietary changes or repeated
antibiotic intervention. Pathogens may
then be viewed as invasive species in
the ecological sense, constantly testing the
resilience of the native ecosystem, resulting
in their elimination, low-level persistence
(enabling future opportunism), or estab-
lishment causing disease.
AGE- AND ENVIRONMENT-RELATED
CHANGES IN THE GUT MICROBIOTA
The most noticeable feature in the micro-
biota of elderly individuals is an alter-
ation in the relative proportions of the
Firmicutes and the Bacteroidetes, with
the elderly having a higher propor-
tion of Bacteroidetes while young adults
have higher proportions of Firmicutes
(Mariat et al., 2009). Significant decreases
in Bifidobacteria, Bacteriodes, and
Clostridium cluster IV have also been
reported (Zwielehner et al., 2009).
Variability among individuals ranges
from 3% to 92% for Bacteroidetes and
between 7% and 94% for Firmicutes. The
microbiota of individual subjects however
exhibit less temporal variability (Claesson
et al., 2011).
Changes occurring in the microbiota
during aging can have an impact on host
health. van Tongeren et al. (2005) studied
the relationship between microbial diver-
sity and frailty scores in elderly individuals.
A significant reduction in the propor-
tion of lactobacilli, Bacteroides/Prevotella
and Faecalibacterium prausnitzii, and an
increase in theproportionofRuminococcus,
Atopobium, and Enterobacteriaceae was
seen in individuals with high frailty scores.
Recently, Claesson et al. (2012) stud-
ied the relationship between diet, host
health, environment, and the gut micro-
biota. Specifically, associationwasobserved
between microbial diversity and the func-
tional independence measure (FIM), the
Barthel index (used to evaluate perfor-
mance in daily routine activities) and
nutrition. Decreased microbial diversity
correlated with increased frailty, decreased
diet diversity and health parameters, and
with increased levels of inflammatory
markers. Individuals living in a community
had the most diverse microbiota and were
healthier as compared to those in short- or
long-term residential care. Bartosch et al.
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(2004) reported that hospitalization itself
appeared toresult inadecreasedabundance
of the Bacteroides-Prevotella group. Later
studies by Claesson et al. (2012) further
detailed the effects of residence location on
gut microbial diversity. Residence location
also affects the microbiota of patients on
antibiotic treatment, with highest levels of
bifidobacteria in the community-dwelling
group and lowest in those in long-term
residential care. The levels of Lactobacillus
in the antibiotic-untreated group were
higher in rehabilitation (hospital stay <
6 weeks) as compared to long-stay or
community-dwellers.
Predictably, antibiotic treatment has
been reported to affect both richness and
diversity of the microbiota and is asso-
ciated with decreases in bifidobacteria
(Bartosch et al., 2004; Woodmansey et al.,
2004; O’Sullivan et al., 2013) as well as
the Bacteroides-Prevotella group (Bartosch
et al., 2004; Woodmansey et al., 2004).
Lactobacilli, however, are observed to have
increased in antibiotic-treated elderly sub-
jects (Woodmansey et al., 2004; O’Sullivan
et al., 2013); similarly, an increase in
clostridial diversity has also been reported
(Woodmansey et al., 2004). The changes
taking place in response to antibiotics are
more apparent at the genus rather than
the family or phylum levels (O’Sullivan
et al., 2013). Treatment with antibiotics
can result in Clostridium difficile infec-
tion in the elderly, manifesting as C. diffi-
cile-associated diarrhea (CDAD). Reduced
species diversity in CDAD patients com-
pared to healthy elderly and young adults
accompanied by a large reduction in bifi-
dobacteria, Bacteroides, and Prevotella has
been reported (Hopkins and MacFarlane,
2002). However, an increase in facultative
bacteria along with an increase in diver-
sity of clostridial and lactobacilli species in
CDAD patients was reported in the same
study. A recent study also detected differ-
ences at the genus level between C. diffi-
cile -negative and -positive subjects, and
patients with CDAD (Rea et al., 2012).
Incidentally, the isolation of the hyper-
virulent C. difficile R027 ribotype from
one asymptomatic individual in this study
who exhibited greater microbial diver-
sity compared to CDAD patients, serves
to highlight the importance of an intact
and unperturbed gut ecosystem in resist-
ing colonization by pathogens. Restoration
of the microbiota and curing CDAD by
fecal microbiota transplantation (FMT)
in recent years presents a novel ther-
apeutic strategy that is under intense
scrutiny (for a discussion see Vrieze
et al., 2013). In contrast to antibiotics,
the common usage of non-steroidal anti-
inflammatory drugs (NSAIDs) does not
appear to significantly perturb the micro-
biota (Tiihonen et al., 2008; Mäkivuokko
et al., 2010).
Interestingly, centenarians harbor less
diverse microbiota, though Bacteroidetes
and Firmicutes still constitute the dom-
inant phyla (Biagi et al., 2010), with
enrichment for potentially pathogenic
Proteobacteria. Biagi et al. (2010) reported
higher levels of Akkermansia in the elderly,
compared to young adults, in contrast to
an earlier study (Collado et al., 2007) that
reported a decrease in this genus with age.
Subsequent functional microbiome pro-
filing of selected, well-characterized sam-
ples from this cohort indicated increased
abundance of genes involved in aromatic
amino acid metabolism, decreased abun-
dance of those involved in short-chain
(≤6) fatty acid production and an enrich-
ment of “pathobionts”—low-abundance
microbiota that promote and sustain
pro-inflammatory conditions (Rampelli
et al., 2013). This supports an ear-
lier finding by Collino et al. (2013)
that increased levels of phenylacetylglu-
tamine (PAG) and p-cresol-sulfate (PCS),
derived from the catabolism of aromatic
amino acids, were excreted in the urine
of centenarians. Thus, the changes in
the gut microbiota of the elderly are
reflected in the changes in the microbial
metabolism.
FROM CORRELATION TO
CAUSALITY—SOME GENERAL
CONSIDERATIONS
High-throughput analytical tools and
meta-“omics” enable probing of the host-
microbiota relationship at high resolution,
helping correlate healthy or diseased states
with the detailed composition of the
microbiota, and informing the use of well-
characterized (e.g., probiotic) or largely
unknown (e.g., stool transplants) mix-
tures of microorganisms for restorative
or maintenance purposes. However, com-
plicating matters further is the existence
of distinct ecological niches all along the
alimentary canal, indicating that the com-
mon (and convenient) method of fecal
sampling for microbiota studies may not
adequately reflect the situation in vivo
(Li et al., 2011). Ideally, we would like to
determine the identity of the molecules
that mediate host-microbiota interactions,
and how their deployment is regulated.
Here, information about host-pathogen
interactions and general microbiology
offers insights into the range of intra-
and inter-species interactions, and even
inter-kingdom ones (Table 1). However,
given our current inability to convincingly
delineate the contextually most significant
effector mechanisms involved in the host-
microbiota interaction over a lifetime, it
is difficult to tease apart causality from
correlation. Moreover, the host and the
microbiota impact each other reciprocally,
and the microbiota themselves interact in
many modes among themselves. While
current host signals may modulate the
microbiota, it is an open question whether
these signals themselves were induced, at
least in some measure by components of
the microbiota themselves. Theoretically,
the host could also modulate the micro-
biota so that microbial responses are, in
turn, beneficial to itself. The landmark
study of Claesson et al. (2012) points to
the possibility of such a reciprocal (and
more confusingly, recursive) relation-
ship between host health and microbial
diversity.
From an evolutionary standpoint, we
would also like to know how much these
interactions and associations are modu-
lated over the host lifetime and during co-
evolution in order to benefit both partners.
Their persistence is also dependent on the
forces of selection operative at a given time
(Sancar, 2008; Lukeš et al., 2011), such as
bacteriophage infection (Reyes et al., 2012;
Koskella, 2013). The recent discovery that
an unknown secreted protein from human
intestinal cells decreases conjugation effi-
ciency in E. coli indicates that the host can
potentially influence the composition, the
rate of evolution and lateral gene trans-
fer among its microbiota (Machado and
Sommer, 2014). An unexplored consid-
eration is the potential influence of host
hormones and their changing levels over
age on the microbiota. Additionally, the
relative abundance of a given enterotype or
species may also not be an unambiguous
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Table 1 | Examples of effector mechanisms involved in inter-species and inter-kingdom interactions.
Effector molecule(s) Relevant aspects for microbiota studies Reference(s)
Secreted phosopholipases (PldA
and PldB) of Pseudomonas
aeruginosa.
Killing of competing bacteria (PldA, PldB), promoting P. aeruginosa
internalization by host cells (PldB).
Russell et al., 2013; Jiang et al.,
2014
Autoinducer-2 (AI-2) Mediates inter-species signaling among the microbiota. Production of
AI-2 by Bifidobacterium breve UCC2003 (a probiotic strain) is required
for gut colonization and protection against Salmonella infection in
C. elegans.
Christiaen et al., 2014
Autoinducer-3 (AI-3), epinephrine
and norepinephrine
Autoinducer 3 (AI-3) produced by the intestinal microbiota can
cross-signal with host hormones epinephrine and norepinephrine.
Sperandio et al., 2003
Epinephrine/Norepinephrine can be sensed by enterohemorrhagic
E. coli, inducing the expression of the LEE pathogenicity island and the
flagella regulon. The AI-3 signaling cascade is conserved across several
bacterial species.
Reading and Sperandio, 2006
predictor of relative importance in the eco-
logical sense. Therefore, identifying key-
stone species that might have an effect
on the ecosystem disproportionate to their
abundance would be very valuable for
focused studies of the microbiota. We sur-
mise that the benefits arising from pro-
biotic administration could be due to
their temporary assumption of such a
“keystone” role. Notably, current studies
of microbiota concentrate solely on the
doubtlessly important bacteria, omitting
archaea and clinically relevant eukaryotes
(fungi), an approach that could poten-
tially miss less abundant but neverthe-
less important species. A recent finding
on the important role of Dectin-1, a C-
type lectin receptor and an innate immune
sensor of fungi, in preventing intesti-
nal colitis-associated pathology underlines
the importance of interactions between
the human host and the numerically less
abundant intestinal fungi (Iliev et al.,
2012).
Natural selection operates simultane-
ously at multiple ecological levels, ranging
from single unicellular organisms to entire
communities and ecosystems. The magni-
tude and relative importance of multiple,
and often stochastic, selection pressures
acting over a human lifetime, therefore
need careful consideration. Thus, it could
be inaccurate to ascribe a given micro-
biota profile solely to a single factor (e.g.,
diet) even though there may be some
correlation between the said profile and
a single contributing factor (see review
by Yeoman et al., 2011). Additionally,
non-equilibrium (co-) evolutionary pro-
cesses may not necessarily result in opti-
mality. Rather, they are governed by the
actual functionality of the given arrange-
ment (“phenotype”) and its ability to
propagate itself (fitness), not on the details
of the arrangement itself (components,
genotypes etc.). Microbiota research, in
the context of aging or otherwise, will
greatly benefit from the integration of sev-
eral disparate pieces of mechanistic infor-
mation within an evolutionary-ecological
framework in order to determine the
causes underlying our observations, and
the formulation of plausible mechanistic
models describing how these causes result
in the observed effects.
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